In individuals with APS-1, antibodies against IFN-ɑ and IFN-⍵ are frequently present, and moderate or severe COVID-19 has been described in SARS-CoV-2 infected APS-1 patients [45–47]. This evidence concerns the gene IFNA1 and COVID-19.